All Posts
M-A | Beneficial and harmful effects of monoclonal antibodies for the treatment and prophylaxis of COVID-19.
27 Jul, 2022 | 12:12h | UTC
AGA Clinical Practice Update | Diagnosis and management of nonalcoholic fatty liver disease in lean individuals.
27 Jul, 2022 | 12:11h | UTCCommentaries:
New Guidelines Focus on NAFLD in Lean People – Medscape (free registration required)
RCT | Effectiveness of intensive home treatment as a substitute for hospital admission in acute psychiatric crisis resolution.
27 Jul, 2022 | 12:08h | UTCThe effectiveness of intensive home treatment as a substitute for hospital admission in acute psychiatric crisis resolution in the Netherlands: a two-centre Zelen double-consent randomised controlled trial – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary: Intensive home treatment effective in place of hospital admission for psychiatric crisis – Healio (free registration required)
Commentary on Twitter
https://twitter.com/TheLancetPsych/status/1544594945331412992
Review | The effect of overlapping surgical scheduling on operating theatre productivity.
27 Jul, 2022 | 12:03h | UTC
M-A | Treating eosinophilic esophagitis with budesonide.
27 Jul, 2022 | 12:06h | UTC
Cohort Study | Incidence of revision surgery after decompression with vs. without fusion among patients with degenerative lumbar spinal stenosis.
27 Jul, 2022 | 11:59h | UTCInvited Commentary: Fusion Is Not a Safeguard to Prevent Revision Surgery in Lumbar Spinal Stenosis – JAMA Network Open
Commentary on Twitter
This cohort study found no association between the type of index operation—decompression alone or fusion—and the need of revision surgery or the outcomes pain, disability & quality of life after 3 years in patients with degenerative lumber spinal stenosis. https://t.co/GZUhkWYzbl
— JAMA Network Open (@JAMANetworkOpen) July 26, 2022
RCT | Effect of intravitreal Aflibercept vs. Laser Photocoagulation on treatment success of retinopathy of prematurity.
27 Jul, 2022 | 12:01h | UTCEffect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
Cohort Study | Association of cerebrospinal fluid neurofilament heavy protein levels with clinical progression in patients with Parkinson disease.
27 Jul, 2022 | 11:58h | UTC
M-A | Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression.
27 Jul, 2022 | 11:55h | UTC
RCT | Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis.
27 Jul, 2022 | 11:56h | UTCIntra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT) – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentaries:
Botulinum toxin A injection may ease base-of-thumb osteoarthritis pain – medwire News
Commentary on Twitter
NEW RESEARCH—Intra-articular botulinum toxin A injection for painful base-of-thumb #osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT) https://t.co/pY4ZQdW6p9 @cchnguyen pic.twitter.com/KT4XLzhIlb
— The Lancet Rheumatology (@TheLancetRheum) June 24, 2022
NICE Guideline | Pneumonia in adults: diagnosis and management.
26 Jul, 2022 | 13:37h | UTCPneumonia in adults: diagnosis and management – National Institute for Health and Care Excellence
Related Guidelines:
Pneumonia (community-acquired): antimicrobial prescribing
Pneumonia (hospital-acquired): antimicrobial prescribing
Cohort Study | Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors.
27 Jul, 2022 | 11:53h | UTCLong-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors – Cancer
Commentaries:
CVD Mortality Leading Cause of Death for Stage I, II Hodgkin Lymphoma – HealthDay
20-year follow-up of a RCT trial | Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy.
26 Jul, 2022 | 13:33h | UTCCommentary: Immunosuppression may benefit long term in virus-negative inflammatory cardiomyopathy – Healio (free registration required)
Commentary on Twitter
Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial@escardio @ESC_Journals #CardioTwitter #EHJhttps://t.co/XpZj0UrJo5 pic.twitter.com/PIq0Bzwhpu
— EHJ Editor-in-Chief (@ehj_ed) July 19, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Cohort Study | Cardiometabolic outcomes up to 12 months after COVID-19 infection.
26 Jul, 2022 | 13:30h | UTCNews Release: COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection – PLOS
Commentaries:
COVID-19 tied to new-onset, short-term heart disease, diabetes – CIDRAP
CVD, Diabetes Spike in Acute Phase of COVID-19 – TCTMD
M-A | Effectiveness of wearable activity trackers to increase physical activity and improve health.
26 Jul, 2022 | 13:27h | UTC
Commentary on Twitter
Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses https://t.co/JecWHjcnpg pic.twitter.com/MPnQHU1VQQ
— Søren T. Skou (@STSkou) July 21, 2022
Under a CC BY-NC-ND 4.0 license
Cohort Study | Laparoscopically confirmed endometriosis and risk of incident stroke.
26 Jul, 2022 | 13:25h | UTCLaparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study – Stroke (free for a limited period)
News Release: Women with endometriosis may have higher risk of stroke – American Heart Association
Commentary: Endometriosis Linked to Greater Risk for Stroke – HealthDay
Commentary on Twitter
Just Published in #Stroke: Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study @l_farland #AHAJournals https://t.co/e2gYhwtO9X pic.twitter.com/dOykgstzN3
— Stroke AHA/ASA (@StrokeAHA_ASA) July 21, 2022
Systematic Review | Antiplatelet agents for the treatment of deep venous thrombosis.
26 Jul, 2022 | 12:44h | UTCAntiplatelet agents for the treatment of deep venous thrombosis – Cochrane Library
Summary: Aspirin and similar drugs for the treatment of deep vein thrombosis (DVT) – Cochrane Library
Central venous catheter (CVC) management: evidence round-up.
26 Jul, 2022 | 12:41h | UTCCentral venous catheter (CVC) management: evidence round-up – Cochrane Library
Systematic Review | Heparin vs. 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
26 Jul, 2022 | 12:43h | UTCRelated: Central venous catheter (CVC) management: evidence round-up – Cochrane Library
Consensus on magnetic resonance imaging of endolymphatic hydrops in patients with suspected hydropic ear disease (Meniere).
26 Jul, 2022 | 12:40h | UTCEditorial: Editorial: Hydropic Ear Disease: Imaging and Functional Evaluation – Frontiers in Surgery
Commentary: Guidance Issued for MR Imaging of Endolymphatic Hydrops – HealthDay
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals.
26 Jul, 2022 | 12:36h | UTCNews Release: Fat build-up in liver (NAFLD) linked to heightened heart failure risk over next decade – BMJ
Commentary: NAFLD Tied to Higher Risk of Heart Failure — Meta-analysis showed a modest risk independent of key risk factors – MedPage Today (free registration required)
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
26 Jul, 2022 | 12:38h | UTCNews Release: A healthy lifestyle can offset a high genetic risk for stroke – University of Texas Health Science Center at Houston
Commentary: Lifetime Risk for Stroke Varies With Genetic Risk, Cardiovascular Health – HealthDay
M-A | Effect of buttonhole cannulation versus rope-ladder cannulation in hemodialysis patients with vascular access.
26 Jul, 2022 | 12:32h | UTC
M-A | Toxicity profiles of systemic therapies for advanced hepatocellular carcinoma.
26 Jul, 2022 | 12:34h | UTC
Commentary on Twitter
This meta-analysis of 30 high-quality RCTs in patients with advanced hepatocellular carcinoma found that immune checkpoint inhibitors were associated with similar liver toxicity but lower serious adverse events compared to tyrosine kinase inhibitors. https://t.co/i0gJg0bqdX
— JAMA Network Open (@JAMANetworkOpen) July 18, 2022
RCT | Safety and efficacy of Liraglutide vs. Colesevelam for treating bile acid diarrhea.
26 Jul, 2022 | 12:29h | UTCSafety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary: Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial — Liraglutide proves superior to colesevelam for cutting daily stool frequency in Danish trial – MedPage Today (free registration required)
Commentary on Twitter
New research – Kårhus et al – Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialhttps://t.co/7Q69CcvjcJ#BAD #GITwitter @MKarhus @filip_Knop pic.twitter.com/lkfSLLgokO
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) July 20, 2022